Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.21 -0.02 (-0.91%)
As of: Sep 29, 2026 · 3:40 PM EDT

Xtl Biopharmaceuticals (XTLB) Notes Payables (2024 - 2025)

Updated

Xtl Biopharmaceuticals (XTLB) recorded Notes Payables of $138,000 in the quarter ended Dec 31, 2025, unchanged from $138,000 a year earlier.

Analysis

Xtl Biopharmaceuticals (XTLB) Notes Payables (2024 - 2025) Analysis & Trends

  • Across earlier years, Notes Payables came in at $138,000 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Xtl Biopharmaceuticals 2.11 Bn 2.11 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 138,000.00
Dec 31, 2024 138,000.00
API Access

Xtl Biopharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=XTLB&period=max&api_key=YOUR_API_KEY